A severe course of the COVID-19 in a patient receiving prophylactically lithium

Karolina Gattner; Janusz Rybakowski

eISSN: 2449-9315
ISSN: 1234-8279

Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii

Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Without publication fees

Open access

2/2020
vol. 36

Send email

Copy url:

Case report

A severe course of the COVID-19 in a patient receiving prophylactically lithium

Karolina Gattner

¹

,

Janusz Rybakowski

²

Centrum Psychiatryczne Szpitala HCP w Poznaniu
Klinika Psychiatrii Dorosłych, Uniwersytet Medyczny w Poznaniu

Farmakoterapia w Psychiatrii i Neurologii 2020, 36 (2), 143–148

Online publish date: 2021/12/06

Article file

- 05R_IPiN_FARM_2020-2B.pdf [0.11 MB]

Get citation

1. Amsterdam JD, García-España F, Rybakowski J. Rates of flu like infection in patients with affective illness. J Affect Disord 1998; 47: 177-182

2. Lieb J. Remission of recurrent herpes infection during ther apy with lithium. N Eng J Med 1979; 301: 942.

3. Murru A, Manchia M, Hajek T, Nielsen RE, Rybakowski JK, Sani G, et al. Lithium’s antiviral effects: a potential drug for CoViD disease? Int J Bipolar Disord 2020; 8: 21.

4. Nowak JK, Walkowiak J. Lithium and coronavirus infections. A scoping review. F1000Research 2020; 9: 93.

5. Rybakowski JK, Amsterdam JD. Lithium prophylaxis and recurrent labial herpes infections. Lithium 1991; 2: 43-47.

6. Rybakowski JK, Suwalska A, Hajek T. Clinical perspectives of lithium’s neuroprotective effect. Pharmacopsychiatry 2018; 51: 194-199.

7. Rybakowski JK. Antiviral and immunomodulatory effect of lithium. Pharmacopsychiatry 2000; 33: 159-164.

8. Rybakowski J. Informacja dotycząca stosowania litu w okre sie pandemii Covid-19. Psychiatra 2020; 28: 48–49.

9. Severus E, Taylor MJ, Sauer C, Pfennig A, Ritter P, Bauer M, et al. Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis. Int J Bipolar Disord 2014; 2: 15.

10. Skinner G.R.B., Hartley C., Buchan A., Harper L, Gallimore P. The effect of lithium chloride on the replication of herpes simplex virus. Med Microbiol Immunol 1980; 168: 258-265.

11. Smith K.A., Cipriani A. Lithium and suicide in mood dis orders: Updated meta-review of the scientific literature. Bipolar Disorders 2017; 19: 575-586

A severe course of the COVID-19 in a patient receiving prophylactically lithium

Karolina Gattner 1 , Janusz Rybakowski 2

Karolina Gattner

¹

,

Janusz Rybakowski

²